Free fatty acids regulate insulin secretion from pancreatic β cells through GPR40
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Diabetes, a disease in which carbohydrate and lipid metabolism are regulated improperly by insulin, is a serious worldwide health issue. Insulin is secreted from pancreatic beta cells in response to elevated plasma glucose, with various factors modifying its secretion. Free fatty acids (FFAs) provide an important energy source as nutrients, and they also act as signalling molecules in various cellular processes, including insulin secretion. Although FFAs are thought to promote insulin secretion in an acute phase, this mechanism is not clearly understood. Here we show that a G-protein-coupled receptor, GPR40, which is abundantly expressed in the pancreas, functions as a receptor for long-chain FFAs. Furthermore, we show that long-chain FFAs amplify glucose-stimulated insulin secretion from pancreatic beta cells by activating GPR40. Our results indicate that GPR40 agonists and/or antagonists show potential for the development of new anti-diabetic drugs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The binding and subsequent interaction of long-chain FFAs with the G-protein-coupled free fatty acid receptor (FFAR) 1 in the pancreatic β-cells leads to the activation of phospholipase C. PLC then hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) to diacylglycerol and inositol-1,4,5-triphosphate (IP3), with the latter docking on a calcium channel in the endoplasmic reticulum. The subsequent”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [94]
In the citing paper
“Activation of FFAR1 elevates [Ca2+]i and stimulates insulin secretion in a glucose-dependent fashion (306).”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [306]
Citations
Cites
Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas
Lacy, P. E., & Kostianovsky, M. (1967) · Diabetes · doi:10.2337/diab.16.1.35 · Cited by 2,751
A G Protein-coupled Receptor Responsive to Bile Acids
Kawamata, Y., Fujii, R., Hosoya, M., Harada, M., Yoshida, H., Miwa, M., Fukusumi, S., Habata, Y., Itoh, T., Shintani, Y., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209706200 · Cited by 1,628 · cited 1×
“MAP kinase MAP kinase activation in CHO and MIN6 cells after treatment with 10 µM of each FFA was determined as described previousl”
MethodSelf-citationCloning of the β Cell High-Affinity Sulfonylurea Receptor: a Regulator of Insulin Secretion
Aguilar-Bryan, L., Nichols, C. G., Wechsler, S. W., Clement, J. P., Boyd, A. E., González, G., Herrera-Sosa, H., Nguy, K., Bryan, J., & Nelson, D. A. (1995) · Science · doi:10.1126/science.7716547 · Cited by 1,315
MIYAZAKI, J.-I., ARAKI, K., YAMATO, E., IKEGAMI, H., ASANO, T., SHIBASAKI, Y., OKA, Y., & YAMAMURA, K.-I. (1990) · Endocrinology · doi:10.1210/endo-127-1-126 · Cited by 1,266
Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin, J. C. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1751 · Cited by 1,201 · cited 1×
“Insulin is secreted from pancreatic β cells in response to elevated plasma glucose, with various factors modifying its secretio”
BackgroundThe Orphan G Protein-coupled Receptor GPR40 Is Activated by Medium and Long Chain Fatty Acids
Briscoe, C. P., Tadayyon, M., Andrews, J. L., Benson, W. G., Chambers, J. K., Eilert, M. M., Ellis, C., Elshourbagy, N. A., Goetz, A. S., Minnick, D. T., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211495200 · Cited by 1,104 · cited 1×
“Although it has been reported that FFAs activate GPR40 and that GPR40 is highly expressed in pancreatic β cell”
BackgroundFree Fatty Acids and Pathogenesis of Type 2 Diabetes Mellitus
BERGMAN, R., & ADER, M. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00323-4 · Cited by 622 · cited 1×
“: in short-term exposure, FFAs enhance GSIS but under long-term exposure they act to attenuate it; an effect called lipotoxicit”
BackgroundA prolactin-releasing peptide in the brain
Hinuma, S., Habata, Y., Fujii, R., Kawamata, Y., Hosoya, M., Fukusumi, S., Kitada, C., Masuo, Y., Asano, T., Matsumoto, H., et al. (1998) · Nature · doi:10.1038/30515 · Cited by 563 · cited 1×
“Previously, we established a strategy to identify ligands by detecting signal transductions in cells expressing orphan GPCR”
BackgroundSelf-citationMETABOLIC COUPLING FACTORS IN PANCREATIC β-CELL SIGNAL TRANSDUCTION
Newgard, C. B., & McGarry, J. D. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003353 · Cited by 531 · cited 1×
“Although several studies have proposed possible mechanisms for FFA-amplified GSIS—for example, that FFAs might simply provide energy to β cells or, alternatively, that the metabolites of FFAs, fatty acyl-coenzyme A molecules, act to stimulate insulin secretio”
BackgroundWank, S. A., Harkins, R., Jensen, R. T., Shapira, H., de Weerth, A., & Slattery, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3125 · Cited by 403 · cited 1×
“Its expression was comparable to that of type A cholecystokinin recepto”
Result
Cited by
Items 401–500 of 1,001
Solid phase synthesis and SAR of small molecule agonists for the GPR40 receptor
McKeown, S. C., Corbett, D. F., Goetz, A. S., Littleton, T. R., Bigham, E. C., Briscoe, C. P., Peat, A. J., Watson, S. P., & Hickey, D. M. B. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.084 · Cited by 71
Role of Mitochondria in β-cell Function and Dysfunction
Maechler, P., Li, N., Casimir, M., Vetterli, L., Frigerio, F., & Brun, T. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-90-481-3271-3_9 · Cited by 68
“Moreover, fatty acids stimulate the G-protein-coupled receptor GPR40/FFAR1 that is highly expressed in β-cells [94].”
BackgroundSchönfeld, P., & Reiser, G. (2016) · Aging and disease · doi:10.14336/ad.2015.0823 · Cited by 67
Metabolic signaling of ceramides through the FPR2 receptor inhibits adipocyte thermogenesis
Lin, H., Ma, C., Cai, K., Guo, L., Wang, X., Lv, L., Zhang, C., Lin, J., Zhang, D., Ye, C., et al. (2025) · Science · doi:10.1126/science.ado4188 · Cited by 81
Natalicchio, A., Labarbuta, R., Tortosa, F., Biondi, G., Marrano, N., Peschechera, A., Carchia, E., Orlando, M. R., Leonardini, A., Cignarelli, A., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3028-4 · Cited by 79
“GPR40 is highly expressed in pancreatic beta cells and insulin-secreting cell lines, is activated by NEFAs, and plays an important role in the chain of events linking hyperinsulinaemia, obesity and type 2 diabetes [24, 25].”
BackgroundNavarro‐Tito, N., Soto-Guzmán, A., Castro‐Sánchez, L., Martinez-Orozco, R., & Salazar, E. P. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.010 · Cited by 74
Fat storage in pancreas and in insulin-sensitive tissues in pathogenesis of type 2 diabetes
Assimacopoulos‐Jeannet, F. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802857 · Cited by 71
Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3
Milligan, G., Stoddart, L. A., & Smith, N. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00421.x · Cited by 68
“…as well as the group of related GPCRs named free fatty acid receptors FFA1, FFA2 and FFA3 (previously designated GPR40, GPR43 and GPR41 respectively) (Briscoe et al., 2003; Brown et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003; Le Poul et al., 2003; see Stoddart et al., 2008a for review).”
BackgroundResultNew Frontiers in Gut Nutrient Sensor Research: Free Fatty Acid Sensing in the Gastrointestinal Tract
Miyauchi, S., Hirasawa, A., Ichimura, A., Hara, T., & Tsujimoto, G. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09r09fm · Cited by 67
Kebede, M. A., Ferdaoussi, M., Mancini, A. D., Alquier, T., Kulkarni, R., WALKER, M. D., & Poitout, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114350109 · Cited by 77
Review: Free fatty acid receptors: emerging targets for treatment of diabetes and its complications
Lee Kennedy, R., Vangaveti, V., Jarrod, G., Shashidhar, V., Shashidhar, V., & Baune, B. T. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810381066 · Cited by 67
“FFAR1 was described independently by three groups [Briscoe et al. 2003; Itoh et al. 2003; Kotarsky et al. 2003].”
MethodMatoba, A., Matsuyama, N., Shibata, S., Masaki, E., Emala, C. W., & Mizuta, K. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00129.2017 · Cited by 74
“Human FFAR1 is classically coupled to both G q and/or G i proteins (8, 35, 61, 68).”
BackgroundSignaling Mechanisms Underlying the Release of Glucagon-Like Peptide 1
Reimann, F., Ward, P. S., & Gribble, F. M. (2006) · Diabetes · doi:10.2337/db06-s010 · Cited by 68
“GPR40 is highly expressed in insulinoma cells and is postulated to play a role in fatty acid modulation of insulin release (59).”
BackgroundChristiansen, E., Urban, C., Grundmann, M., Due‐Hansen, M. E., Hagesæther, E., Schmidt, J., Pardo, L., Ullrich, S., Kostenis, E., Kassack, M. U., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2005699 · Cited by 69
Free Fatty Acid Receptors as new potential therapeutic target in inflammatory bowel diseases
Bartoszek, A., Moo, E. V., Binienda, A., Fabisiak, A., Krajewska, J. B., Mosińska, P., Niewinna, K., Tarasiuk, A., Martemyanov, K. A., Sałaga, M., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104604 · Cited by 66
Kyriazis, G. A., Smith, K. R., Tyrberg, B., Hussain, T., & Pratley, R. E. (2014) · Endocrinology · doi:10.1210/en.2013-2015 · Cited by 67
GPR40 modulates epileptic seizure and NMDA receptor function
Yang, Y., Tian, X., Xu, D., Zheng, F., Lu, X., Zhang, Y., Ma, Y., Li, Y., Xu, X., Zhu, B., et al. (2018) · Science Advances · doi:10.1126/sciadv.aau2357 · Cited by 69
“GPR40 is abundantly expressed in cells in pancreatic islets, and many studies have confirmed its role in regulating insulin secretion (4).”
Qiu, T., Yang, X., Wang, J., Pan, C., Chu, X., Xiong, J., Xie, J., Chang, Y., Wang, C., & Zhang, J. (2022) · Nutrition and Diabetes · doi:10.1038/s41387-022-00202-6 · Cited by 68
Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammation
Wu, W., Sui, W., Chen, S., Guo, Z., Jing, X., Wang, X., Wang, Q., Yu, X., Xiong, W., Ji, J., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.006 · Cited by 71
Vettor, R., Granzotto, M., Stefani, D. D., Trevellin, E., Rossato, M., Farina, M. G., Milan, G., Pilon, C., Nigro, A., Federspil, G., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2680 · Cited by 75
“fat diet does not necessarily disprove this hypothesis because GPR40expression was not documented in mouse or rat brain (10, 13, 14, 28 ).”
BackgroundPotential roles of GPR120 and its agonists in the management of diabetes
Leung, P. S., & Zhang, D. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s53892 · Cited by 80
“45,48,49 On the other hand, BSA blunts the potency of FFAs to activate GPCRs, as it can influence interaction between FFAs and GPCRs. 11,50,51”
Keane, D., Takahashi, H., Dhayal, S., Morgan, N. G., Curi, R., & Newsholme, P. (2010) · Clinical Science · doi:10.1042/cs20100282 · Cited by 66
Mattes, R. D. (2009) · Chemical Senses · doi:10.1093/chemse/bjp015 · Cited by 65
Negoro, N., Sasaki, S., Ito, M., Kitamura, S., Tsujihata, Y., Ito, R., Suzuki, M., Takeuchi, K., Suzuki, N., Miyazaki, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2012968 · Cited by 69
Hyperinsulinemic Hypoglycemia – The Molecular Mechanisms
Nessa, A., Rahman, S. A., & Hussain, K. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00029 · Cited by 72
Rethinking the central causes of diabetes
Elmquist, J. K., & Marcus, J. (2003) · Nature Medicine · doi:10.1038/nm0603-645 · Cited by 69
“How might LCFAs regulate cellular events? That remains to be determined, but recent studies have indicated that fatty acids act as membrane ligands of G-protein-coupled receptor”
BackgroundPaulsen, S. J., Larsen, L. K., Hansen, G., Chelur, S., Larsen, P. J., & Vrang, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088227 · Cited by 64
“GPR41 and GPR43 are engaged by short chain fatty acids, GPR84 by medium chain and GPR40 and GPR120 by long chain fatty acids [1,2,3,4].”
Bandak, B., Yi, L., & Roper, M. G. (2018) · Lab on a Chip · doi:10.1039/c8lc00624e · Cited by 69
Hamdouchi, C., Kahl, S. D., Patel Lewis, A., Cardona, G. R., Zink, R. W., Chen, K., Eessalu, T. E., Ficorilli, J. V., Marcelo, M. C., Otto, K. A., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00892 · Cited by 62
‘PUFA–GPR40–CREB signaling’ hypothesis for the adult primate neurogenesis
Yamashima, T. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2012.02.001 · Cited by 71
Unsaturated fatty acids as cytoprotective agents in the pancreatic β-cell
Morgan, N. G., & Dhayal, S. (2010) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2010.02.018 · Cited by 75
Kotarsky, K., Nilsson, N. E., Olde, B., & Owman, C. (2003) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.2003.pto930601.x · Cited by 71
“…seems to play an important physiological role since it modulates insulin secretion from pancreatic b-cells upon stimulation with free fatty acids (Itoh et al. 2003) and also responds to modern antidiabetic drugs (Kotarsky et al. 2003b) of the thiazolidinedione type (Cantello et al. 1994;…”
BackgroundResultHernández‐Cáceres, M. P., Toledo, L., Díaz‐Castro, F., Ávalos, Y., Burgos, P., Narro, C., Peña‐Oyarzún, D., Espinoza-Caicedo, J., Cifuentes-Araneda, F., Navarro-Aguad, F., et al. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00176 · Cited by 69
“Among those, we focused our attention on FFAR1, the activation of which in pancreatic β -cells, leads to insulin secretion (25, 47), suggesting that this receptor might be involved in the chain of events that regulate the insulin response.”
de Souza, C. O., Sun, X., & Oh, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.715877 · Cited by 72
“GPR40 can be activated by medium‐ to long‐chain free fatty acids (FFAs) (76, 79).”
BackgroundPI(18:1/18:1) is a SCD1-derived lipokine that limits stress signaling
Thürmer, M., Gollowitzer, A., Pein, H., Neukirch, K., Gelmez, E., Waltl, L., Wielsch, N., Winkler, R., Loeser, K., Grander, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30374-9 · Cited by 69
New insights into “GPR40‐CREB interaction inadult neurogenesis” specific for primates
Boneva, N. B., & Yamashima, T. (2011) · Hippocampus · doi:10.1002/hipo.20951 · Cited by 68
“In 2003, PUFA were determined as ligands for G protein-coupled receptor 40 (GPR40), a transmembrane receptor highly expressed in the pancreas and brain of humans (Briscoe et al., 2003; Itoh et al., 2003; Kotarsky et al., 2003).”
BackgroundOral fatty acid signaling and intestinal lipid processing: Support and supposition
Mattes, R. D. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.02.016 · Cited by 67
Christiansen, E., Due‐Hansen, M. E., Urban, C., Merten, N., Pfleiderer, M. I. B., Karlsen, K. K., Rasmussen, S., Steensgaard, M., Hamacher, A., Schmidt, J., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100106c · Cited by 64
Arachidonic acid promotes FAK activation and migration in MDA-MB-231 breast cancer cells
Navarro‐Tito, N., Robledo, T., & Salazar, E. P. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.08.018 · Cited by 68
“In support of our proposal, previous reports show that GPR40 and GPR120 are activated by medium and long-chain FFAs, such as oleic, stearic, undecanoic, nonadecanoic [4,6], but to our knowledge there is not any report showing that AA is able to activate GPR40 and/or GPR120.”
BackgroundInfluentialCeja-Galicia, Z. A., Cespedes-Acuña, C. L. A., & El-Hafidi, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020788 · Cited by 61
“In type II diabetes, increased levels of PA induce the loss of the β -cell function due to the involvement of FFAR1 in crosstalk with mTOR-Akt and IRS-1, altering insulin signaling [89–91].”
Welters, H. J., Diakogiannaki, E., Mordue, J. M., Tadayyon, M., Smith, S. A., & Morgan, N. G. (2006) · APOPTOSIS · doi:10.1007/s10495-006-7450-7 · Cited by 69
“For example, both long chain saturated fatty acids and long chain mono-unsaturated fatty acids are reported to be agonistic at GPR40 and this pharmacology does not accord with their differential effects on viability seen here [21, 22].”
Kostenis, E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.04.005 · Cited by 66
Unsaturated Fatty Acids and Pain
Tokuyama, S., & Nakamoto, K. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.1174 · Cited by 73
Pharmacological Targeting of the Mitochondrial Phosphatase PTPMT1
Doughty-Shenton, D., Joseph, J. D., Zhang, J., Pagliarini, D. J., Kim, Y., Lu, D., Dixon, J. E., & Casey, P. J. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163329 · Cited by 63
Li, Z., Chen, Y., Zhou, Z., Deng, L., Xu, Y., Hu, L., Liu, B., & Zhang, L. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.069 · Cited by 63
Bhat, S. A., Ahmad, S. M., Ibeagha-Awemu, E. M., Bhat, B. A., Dar, M. A., Mumtaz, P. T., Shah, R. A., & Ganai, N. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211773 · Cited by 78
Vitamin C for Type 2 Diabetes Mellitus and Hypertension
Das, U. N. (2019) · Archives of Medical Research · doi:10.1016/j.arcmed.2019.05.004 · Cited by 69
A novel class of antagonists for the FFAs receptor GPR40
Hu, H., He, L. Y., Gong, Z. L., Li, N., Lu, Y., Zhai, Q. W., Liu, H., Jiang, H. L., Zhu, W., & Wang, H. Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.004 · Cited by 66
Pappan, K. L., Pan, Z., Kwon, G., Marshall, C. A., Coleman, T., Goldberg, I. J., McDaniel, M. L., & Semenkovich, C. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m409706200 · Cited by 60
Montgomery, M. K., Osborne, B., Brandon, A. E., O’Reilly, L., Fiveash, C. E., Brown, S. H. J., Wilkins, B. P., Samsudeen, A., Yu, J., Devanapalli, B., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900234r · Cited by 67
Li, Z., Qiu, Q., Xu, X. J., Wang, X., Jiao, L., Su, X., Pan, M., Huang, W., & Qian, H. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.02.040 · Cited by 64
Shimano, H. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.004 · Cited by 65
Guerra, S. D., Bugliani, M., D’Aleo, V., Prato, S. D., Boggi, U., Mosca, F., Filipponi, F., & Lupi, R. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.02.008 · Cited by 65
Munakata, Y., Yamada, T., Imai, J., Takahashi, K., Tsukita, S., Shirai, Y., Kodama, S., Asai, Y., Sugisawa, T., Chiba, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19765-5 · Cited by 74
The Difference δ-Cells Make in Glucose Control
Huising, M. O., van der Meulen, T., Huang, J. L., Pourhosseinzadeh, M. S., & Noguchi, G. M. (2018) · Physiology · doi:10.1152/physiol.00029.2018 · Cited by 59
GPR120/FFAR4 Pharmacology: Focus on Agonists in Type 2 Diabetes Mellitus Drug Discovery
Carullo, G., Mazzotta, S., Vega‐Holm, M., Iglesias‐Guerra, F., Vega‐Pérez, J. M., Aiello, F., & Brizzi, A. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01002 · Cited by 71
Auguste, S., Fisette, A., Fernandes, M. F., Hryhorczuk, C., Poitout, V., Alquier, T., & Fulton, S. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw014 · Cited by 59
Costanzi, S., Neumann, S., & Gershengorn, M. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800014200 · Cited by 64
G-protein-coupled receptors as fat sensors
Vinolo, M. A. R., Hirabara, S. M., & Curi, R. (2012) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834f4598 · Cited by 59
Biological Roles and Therapeutic Potential of Hydroxy-Carboxylic Acid Receptors
Ahmed, K. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00051 · Cited by 70
Im, D. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.09.001 · Cited by 69
“However, in several other reports, no change in glucose-stimulated insulin secretion was observed in FFA4 deficient mice (Itoh et al., 2003; Oh et al., 2014; Stone et al., 2014).”
ResultCurrent status of GPR40/FFAR1 modulators in medicinal chemistry (2016–2019): a patent review
Li, Z., Zhou, Z., & Zhang, L. (2019) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2020.1698546 · Cited by 59
Molecular mechanisms underlying nutrient detection by incretin-secreting cells
Reimann, F. (2010) · International Dairy Journal · doi:10.1016/j.idairyj.2009.11.014 · Cited by 61
Modulating GPR40: therapeutic promise and potential in diabetes
Poitout, V., & Lin, D. C.-H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.09.003 · Cited by 62
The weight of nutrients: kynurenine metabolites in obesity and exercise
Dadvar, S., Ferreira, D. M. S., Červenka, I., & Ruas, J. L. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12830 · Cited by 62
Thörn, K., & Bergsten, P. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22734 · Cited by 57
“In addition, FFAs are ligands to the b-cell expressed GPR40 [Briscoe et al., 2003; Itoh et al., 2003], which has further added to the understanding how acute effects of FFAs are translated into enhanced GSIS via PLC-coupled rise of cytoplasmic Ca2þ [Fujiwara et al., 2005].”
BackgroundBaker, E. J., Miles, E. A., & Calder, P. C. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101097 · Cited by 63
Dietary Effects on Incretin Hormone Secretion
Wu, T., Rayner, C. K., Jones, K. L., & Horowitz, M. (2010) · Vitamins and hormones · doi:10.1016/b978-0-12-381517-0.00003-5 · Cited by 62
“, 2008), while another found relatively high GPR40 mRNA expression in the ileum (Itoh et al., 2003), and colocalization of GPR120 with GLP-1 bearing cells has been demonstrated in the ileum, colon, and rectum (Hirasawa et al.”
BackgroundA Cell-Permeable Inhibitor to Trap Gαq Proteins in the Empty Pocket Conformation
Schmitz, A.-L., Schrage, R., Gaffal, E., Charpentier, T. H., Wiest, J. M., Hiltensperger, G., Morschel, J., Hennen, S., Häußler, D., Horn, V., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.06.003 · Cited by 57
“In fact, of the four families of Gα proteins (Gαi/o, Gαs, Gαq/11, and Gα12/13) only Gαi/o proteins can be specifically inhibited with pertussis toxin (PTX), which has served as an invaluable probe to analyze GPCR signaling mechanisms and Gαi-mediated cell responses (Mangmool and Kurose, 2011; Saulière et al., 2012; As…”
BackgroundSchmidt, J., Liebscher, K., Merten, N., Grundmann, M., Mielenz, M., Sauerwein, H., Christiansen, E., Due-Hansen, M. E., Ulven, T., Ullrich, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.200477 · Cited by 58
Odori, S., Hosoda, K., Tomita, T., Fujikura, J., Kusakabe, T., Kawaguchi, Y., Doi, R., Takaori, K., Ebihara, K., Sakai, Y., et al. (2012) · Metabolism · doi:10.1016/j.metabol.2012.06.010 · Cited by 60
Weigert, C., Lehmann, R., Hartwig, S., & Lehr, S. (2014) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201300094 · Cited by 57
Eclov, J. A., Qian, Q., Redetzke, R. A., Chen, Q., Wu, S. C., Healy, C. L., Ortmeier, S. B., Harmon, E. B., Shearer, G. C., & O’Connell, T. D. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m062034 · Cited by 61
Zuccolo, E., Dragoni, S., Poletto, V., Catarsi, P., Guido, D., Rappa, A., Reforgiato, M., Lodola, F., Lim, D., Rosti, V., et al. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.09.005 · Cited by 57
“AA could recruit the PLC/InsP3 signalling pathway by activating the G-protein coupled receptor 40 (GPR40) [63].”
BackgroundInfluentialRedox Signaling from Mitochondria: Signal Propagation and Its Targets
Ježek, P., Holendová, B., & Plecitá‐Hlavatá, L. (2020) · Biomolecules · doi:10.3390/biom10010093 · Cited by 62
Molecular mechanisms of lipotoxicity-induced pancreatic β-cell dysfunction
Benito‐Vicente, A., Jebari‐Benslaiman, S., Galicia-García, U., Larrea, A., Uribe, K. B., & Martín, C. (2021) · International review of cytology · doi:10.1016/bs.ircmb.2021.02.013 · Cited by 65
Fish Oil Accelerates Diet-Induced Entrainment of the Mouse Peripheral Clock via GPR120
Furutani, A., Ikeda, Y., Itokawa, M., Nagahama, H., Ohtsu, T., Furutani, N., Kamagata, M., Yang, Z.-H., Hirasawa, A., Tahara, Y., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0132472 · Cited by 57
“In addition, activation of GPR40 in the pancreas directly increases insulin secretion [13,18].”
BackgroundInfluentialDiscovery of new G protein-coupled receptors for lipid mediators
Im, D. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300006-jlr200 · Cited by 61
“Three independent groups have reported that GPR40 is a receptor for medium- and long-chain fatty acids, which include saturated fatty acids of 12–16 carbon units and unsaturated fatty acids of 18–20 carbons (9, 10, 13).”
BackgroundInfluentialDiscovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonists
Zhou, C., Tang, C., Chang, E., Ge, M., Lin, S., Cline, E., Tan, C. P., Feng, Y., Zhou, Y., Eiermann, G. J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.052 · Cited by 56
Christiansen, E., Due‐Hansen, M. E., Urban, C., Grundmann, M., Schmidt, J., Hansen, S. V. F., Hudson, B. D., Zaibi, M. S., Markussen, S. B., Hagesæther, E., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301470a · Cited by 59
Sanches, J. R., França, L. M., Chagas, V. T., Gaspar, R. S., dos Santos, K. A., Gonçalves, L. M., Sloboda, D. M., Holloway, A. C., Dutra, R. P., Carneiro, E. M., et al. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00048 · Cited by 70
“Free fatty acids directly stimulate insulin release through activation of G protein-coupled receptor 40 (GPR40) on pancreatic β-cell surface (Itoh et al., 2003).”
BackgroundGq and Gs signaling acting in synergy to control GLP-1 secretion.
Hauge, M., Ekberg, J. H., Engelstoft, M., Timshel, P., Madsen, A. N., & Schwartz, T. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.024 · Cited by 50
Kristinsson, H., Sargsyan, E., Manell, H., Smith, D. M., Göpel, S., & Bergsten, P. (2017) · Scientific Reports · doi:10.1038/s41598-017-04730-5 · Cited by 63
Xiao, J., Cai, T., Fang, Y., Liu, R., Flores, J. J., Wang, W., Gao, L., Liu, Y., Lu, Q., Tang, L., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02209-9 · Cited by 60
β- cell dynamics in type 2 diabetes and in dietary and exercise interventions
Lv, C.-A., Sun, Y., Zhang, Z. Y., Aboelela, Z., Qiu, X., & Meng, Z. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac046 · Cited by 62
“GPR40, also known as FFAR1, is a fatty acid receptor strongly expressed in the pancreas ( Itoh et al., 2003 ) .”
BackgroundLipolysis-Derived Linoleic Acid Drives Beige Fat Progenitor Cell Proliferation via CD36
Abe, I., Oguri, Y., Verkerke, A. R. P., Monteiro, L. D. B., Knuth, C. M., Auger, C., Qiu, Y., Westcott, G. P., Cinti, S., Shinoda, K., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.11.007 · Cited by 60
Mizuta, K., Zhang, Y., Mizuta, F., Hoshijima, H., Shiga, T., Masaki, E., & Emala, C. W. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2015 · Cited by 62
“(25) also showed that EC50 values of either oleic acid- or linoleic acid-stimulated [Ca(2) ]i rise in Chinese hamster ovary (CHO) cells expressing FFAR1 were 2.”
BackgroundInfluentialGPR119: “Double-Dipping” for Better Glycemic Control
Lauffer, L., Iakoubov, R., & Brubaker, P. L. (2008) · Endocrinology · doi:10.1210/en.2008-0182 · Cited by 62
GPCRs involved in metabolic diseases: pharmacotherapeutic development updates
Jin, C., Chen, H., Xie, L. H., Zhou, Y., Liu, L., & Wu, J. H. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01215-2 · Cited by 57
“ERK1/2 activation has been con fi rmed as one of the downstream signalling pathways in GPR40-G α q/11 protein coupling [127].”
GPR40: A therapeutic target for mediating insulin secretion
FENG, X.-T., LENG, J., XIE, Z., LI, S.-L., ZHAO, W., & TANG, Q.-L. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.1142 · Cited by 54
Hidalgo, M. A., Nahuelpan, C., Manosalva, C., Jara, E. L., Carretta, M. D., Conejeros, I., Loaiza, A., Chihuailaf, R. H., & Burgos, R. A. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.144 · Cited by 60
Christiansen, E., Due‐Hansen, M. E., Urban, C., Grundmann, M., Schröder, R. J., Hudson, B. D., Milligan, G., Cawthorne, M. A., Kostenis, E., Kassack, M. U., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3002026 · Cited by 58
PPARβ/δ affects pancreatic β cell mass and insulin secretion in mice
Iglesias, J., Barg, S., Vallois, D., Lahiri, S., Roger, C., Yessoufou, A., Pradevand, S., McDonald, A., Bonal, C., Reimann, F., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci42127 · Cited by 71
“Acute treat-ment of islets with palmitate potentiates GSIS in the β cell, both via intracellular metabolic lipid signaling (19) and the free fatty acid receptor GPR40 (20).”
Recent Advances in Gut Nutrient Chemosensing
Nguyen, C. A., Akiba, Y., & Kaunitz, J. D. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803414033 · Cited by 57
“Itoh and colleagues report that the expression of FFA1 in pancreatic β-cells suggests a regulatory role in insulin release [60].”
BackgroundUnbound free fatty acid profiles in human plasma and the unexpected absence of unbound palmitoleate
Huber, A. H., & Kleinfeld, A. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m074260 · Cited by 53
Kristinsson, H., Bergsten, P., & Sargsyan, E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.09.022 · Cited by 53
Graciano, M. F. R., Santos, L. R. B., Curi, R., & Carpinelli, Â. R. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22432 · Cited by 58
“These results indicate that the increased demand for insulin secretion raises the expression of GPR40 that has been associated with insulin secretion in beta cells (Itoh et al., 2003; Itoh and Hinuma, 2005; Shapiro et al., 2005).”
BackgroundInfluentialSimvastatin Impairs Insulin Secretion by Multiple Mechanisms in MIN6 Cells
Yaluri, N., Modi, S., Rodríguez, M. L., Stančáková, A., Kuusisto, J., Kokkola, T., & Laakso, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142902 · Cited by 57
“GPR40 mediated insulin secretion is dependent on Ca influx into the β-cell [18], and Ca release from intracellular Ca stores, such as endoplasmic reticulum [16].”
BackgroundUrrutia, N. L., & Harvatine, K. J. (2017) · Journal of Dairy Science · doi:10.3168/jds.2016-12369 · Cited by 58
“Conjugated linoleic acid and medium- and long-chain FA have been shown to potentiate insulin secretion in in vivo (mouse) and in vitro (rat and mouse) models through activation of G protein-coupled receptor 40 (GPR-40), which is highly expressed in pancreatic β cells (Itoh et al., 2003; Covington et al., 2006; Schmidt…”
Orally Active Epoxyeicosatrienoic Acid Analogs
Campbell, W. B., Imig, J. D., Schmitz, J. M., & Falck, J. R. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000523 · Cited by 54
Metadata
- Authors
- Itoh, Y., Kawamata, Y., Harada, M., Kobayashi, M., Fujii, R., Fukusumi, S., Ogi, K., Hosoya, M., Tanaka, Y., Uejima, H., Tanaka, H., Maruyama, M., Satoh, R., Okubo, S., Kizawa, H., Komatsu, H., Matsumura, F., Noguchi, Y., Shinohara, T., Hinuma, S., Fujisawa, Y., & Fujino, M.
- Affiliations
- Takeda (Japan) (JP)
- Corresponding author
- Hinuma, Shuji
- ORCID
- Venue
- Nature
- Published
- 2003-02-23
- Volume
- 422
- Issue
- 6928
- Pages
- 173-176
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2128326754
- Cited by
- 1,538
- References
- 26
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 54 · 2023: 51 · 2022: 58 · 2021: 89 · 2020: 74 · 2019: 75 · 2018: 88 · 2017: 89 · 2016: 111 · 2015: 82 · 2014: 84 · 2013: 91 · 2012: 84
- FWCI
- 45.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Heart, Lung, and Blood Institute
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- free fatty acids, GPR40, insulin secretion, pancreatic beta cells, glucose-stimulated insulin secretion, long-chain fatty acids, G protein-coupled receptors, diabetes mellitus, antidiabetic drug development
- MeSH terms
- Insulin Secretion, Animals, Haplorhini, Calcium, Enzyme Activation, Fatty Acids, Nonesterified, Glucose, Cricetinae, Humans, Insulin, Male, Molecular Sequence Data, Pancreas, Receptors, Cell Surface, RNA, Messenger, Transfection, CHO Cells, Rats, Wistar, Calcium Signaling, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, RNA, Small Interfering, Receptors, G-Protein-Coupled, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.